---
document_datetime: 2024-07-29 12:50:09
document_pages: 24
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/suboxone-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: suboxone-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 12.4331063
conversion_datetime: 2025-12-25 12:05:16.929362
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Suboxone

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2113/ 202309   | Periodic Safety Update EU Single assessment - buprenorphine / naloxone                                                                       | 30/05/2024                          | 24/07/2024                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/2113/202309. |
| WS/2621/G            | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No | 01/02/2024                          | n/a                                         |                                  |                                                                                                                                           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | 1234/2008. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |    |            |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|------------|
| IA/0058/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites manufacturer for batch release) | 30/10/2023 | n/a        |    | (excluding |
| N/0057    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 09/10/2023 | 05/01/2024 | PL |            |
| WS/2372/G | This was an application for a group of variations following a worksharing procedure according to                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 20/04/2023 | n/a        |    |            |

<div style=\"page-break-after: always\"></div>

|           | Regulation (EC) No 1234/2008. B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                       |            |            |                    | Article 20 of Commission   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|----------------------------|
| IB/0055   | C.z - Safety, Efficacy, Pharmacovigilance changes - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 16/01/2023 | 05/01/2024 | SmPC and Labelling |                            |
| WS/2324/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 10/11/2022 | n/a        |                    |                            |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or   |            |     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0054/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 14/09/2022 | n/a |

<div style=\"page-break-after: always\"></div>

|           | - Change in test procedure for the finished - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                       | B.II.d.2.a product procedure                     |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|--------------------------------------------------|
| IB/0052   | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 30/08/2021 | 18/07/2022 | SmPC, Annex II and PL |                                                  |
| WS/1993/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.d.1.b.1 - Stability of AS - Change in the storage conditions - Change to more restrictive storage conditions of the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised - Change in test procedure for AS or | 11/03/2021 | n/a        |                       | B.I.b.2.a starting material/reagent/intermediate |

<div style=\"page-break-after: always\"></div>

| changes to an approved B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.2.b - Change in   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| a test procedure for the material/reagent/intermediate, procedure is already authorised B.I.b.2.b - Change in test starting material/reagent/intermediate a test procedure for the material/reagent/intermediate, procedure is already authorised B.I.b.2.b - Change in test starting material/reagent/intermediate a test procedure for the material/reagent/intermediate, procedure is already authorised B.I.b.2.b - Change in test starting material/reagent/intermediate a test procedure for the material/reagent/intermediate, procedure is already authorised B.I.b.2.b - Change in test starting material/reagent/intermediate a test procedure for the material/reagent/intermediate, procedure is already authorised B.I.b.2.b - Change in test starting material/reagent/intermediate a test procedure for the material/reagent/intermediate, procedure is already authorised B.I.b.2.b - Change in test starting material/reagent/intermediate a test procedure for the   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|             | procedure is already authorised B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits A.7 - Administrative change - Deletion of manufacturing sites B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an   |            |            |                        | ASMF   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------|
| IA/0051     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 08/02/2021 | 18/08/2021 | SmPC, Labelling and PL |        |
| IB/0049     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 29/01/2021 | n/a        |                        |        |
| IAIN/0048/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 11/12/2020 | 18/08/2021 | SmPC, Annex            |        |

<div style=\"page-break-after: always\"></div>

|           | A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                    |            |            | II, Labelling and PL   |      |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------|
| IB/0047/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.e.z - Change in container closure system of the Finished Product - Other variation B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate an already approved manufacturer | 17/11/2020 | n/a        |                        | from |
| IB/0046/G | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                        | 26/08/2020 | 18/08/2021 | SmPC, Labelling and PL |      |

<div style=\"page-break-after: always\"></div>

| X/0042             | Annex I_2.(c) Change or addition of a new strength/potency Annex I_2.(d) Change or addition of a new pharmaceutical form Annex I_2.(e) Change or addition of a new route of administration                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 30/04/2020   | 03/07/2020   | SmPC, Labelling and PL   |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-----------------------------------|
| PSUSA/2113/ 201909 | Periodic Safety Update EU Single assessment - buprenorphine / naloxone                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 14/05/2020   | n/a          |                          | PRAC Recommendation - maintenance |
| IAIN/0043/G        | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.c.1 - Change to importer, batch release | 27/03/2019   | n/a          |                          |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | and quality control testing of the FP - or addition of a manufacturer for importation and/or batch release - including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |     | arrangements Replacement responsible Not   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------------------------|
| WS/1489/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting | 21/03/2019 | n/a |                                            |

<div style=\"page-break-after: always\"></div>

|             | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure   |            |            |                        |                                                                                                               |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------|
| IA/0041     | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                   | 15/03/2019 | n/a        |                        |                                                                                                               |
| IAIN/0040/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                  | 13/02/2019 | 04/02/2020 | Annex II and PL        |                                                                                                               |
| T/0038      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                           | 09/05/2018 | 31/05/2018 | SmPC, Labelling and PL |                                                                                                               |
| II/0037     | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission                                                                                                                                                                                                                                                                                                       | 17/05/2018 | n/a        |                        | Analyses from the THIN study showed that the mortality rate appeared lower in the Suboxone user group than in |

<div style=\"page-break-after: always\"></div>

|                    | of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     | the buprenorphine and methadone user groups. Two comparative analyses were conducted using the cohort design with intention-to-treat approach and the nested case control design. Both analyses yielded consistent results that Suboxone was not found associated with any elevated risk for all-cause mortality in comparison to buprenorphine or methadone. Based on the current findings, no safety signal was detected for Suboxone. Therefore, no change to the product information is warranted.   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2113/ 201609 | Periodic Safety Update EU Single assessment - buprenorphine / naloxone                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 05/05/2017 | n/a | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| WS/0934/G          | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method | 23/03/2017 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|             | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised    |            |            |                                  |                                                                          |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------|
| II/0035     | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                              | 09/03/2017 | n/a        |                                  |                                                                          |
| X/0029      | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                                                                                                                                                                                                                                 | 24/09/2015 | 16/11/2015 | SmPC, Annex II, Labelling and PL | Please refer to the scientific discussion Suboxone-H-C- 000697-X-0029-AR |
| IAIN/0033   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                            | 25/08/2015 | n/a        |                                  |                                                                          |
| IAIN/0032/G | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 12/08/2015 | 16/11/2015 | SmPC, Labelling and PL           |                                                                          |

<div style=\"page-break-after: always\"></div>

|           | manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings                  |            |            |             | and/or address of a        |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------------------------|
| II/0030/G | application for a group of variations. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.3.a - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Implementation of by the competent authority | 26/02/2015 | 30/03/2015 | SmPC and PL | This was an wording agreed |
| IA/0031/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                           | 07/01/2015 | n/a        |             |                            |
| IB/0027   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                        | 12/08/2014 | n/a        |             |                            |

<div style=\"page-break-after: always\"></div>

| IAIN/0025   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                   | 21/05/2014   | n/a   |                                   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| PSUV/0023   | Periodic Safety Update                                                                                                                                                                                                                                                                                                                            | 08/05/2014   | n/a   | PRAC Recommendation - maintenance |
| IA/0024     | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                               | 10/04/2014   | n/a   |                                   |
| II/0022     | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                     | 20/03/2014   | n/a   |                                   |
| II/0021     | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                     | 20/03/2014   | n/a   |                                   |
| II/0020     | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                     | 20/03/2014   | n/a   |                                   |
| IAIN/0019/G | This was an application for a group of variations. B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change | 13/12/2013   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|           | comply with an update of the relevant monograph the Ph. Eur. or national pharmacopoeia of a State                                                                                                                                                                                                                                                                                                                                          |            |            |             | to of Member   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------------|
| IAIN/0018 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                            | 07/11/2013 | n/a        |             |                |
| IA/0017   | B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms                                                                                                                                                                                                                                                                                               | 03/09/2013 | 23/05/2014 | SmPC and PL |                |
| IB/0015/G | This was an application for a group of variations. B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an alternative method is already authorised | 11/07/2013 | n/a        |             |                |
| IA/0016/G | This was an application for a group of variations. B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement                                                                                                               | 03/07/2013 | n/a        |             |                |

<div style=\"page-break-after: always\"></div>

|           | or addition of a site where batch control/testing takes place A.7 - Administrative change - Deletion of manufacturing sites B.II.b.3.a - Change in the manufacturing process of the finished product - Minor change in the manufacturing process of an immediate release solid oral dosage form or oral solutions                                                                                                                                                                                                                                      |            |            |                                                                                                                                                                                                                                                               |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0014/G | This was an application for a group of variations. B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                             | 24/06/2013 | n/a        | The Agency considers that the variation listed below is rejected and therefore receives an unfavourable opinion. B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms |
| II/0013/G | This was an application for a group of variations. Changes to the Active Substance Master File (ASMF) for Buprenorphine Hydrochloride. B.I.b.1.g - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Widening of the approved specs for starting mat./intermediates, which may have a significant effect on the quality of the AS and/or the FP B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement | 30/05/2013 | 30/05/2013 |                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| or addition) for the AS material/intermediate B.I.a.2.e - Changes in the AS - Minor change ASMF B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.I.b.1.c - Change in the and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method B.I.b.1.c - Change in the and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.c - Change in the and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0012/G | This was an application for a group of variations. Group of 8 type II variations: - Update to section 4.2 of the SmPC to add a clarification on withdrawal signs based on the literature. - Update to sections 4.4 and 4.6 of the SmPC to add new or revised warning, respectively, on the risk of respiratory depression in non-opioid dependent individuals, children and pregnant women, supported by relevant pharmacovigilance data. - Update to sections 4.4 and 4.8 of the SmPC, to strengthen existing warning on hepatic injury, supported by relevant pharmacovigilance data. - Update to sections 4.4 of the SmPC to strengthen the warning related to the use of suboxone in patient with severe renal impairment, supported by literature reference. - Update to sections 4.4 of the SmPC to strengthen general warning relevant to the administration of opioids, supported by literature references. - Update to section 4.5 of the SmPC to add information on the interaction of suboxone with full opioid agonist supported by literature references. - Update to sections 4.5 and 4.9 of the SmPC | 30/05/2013 | SmPC, Labelling and PL | The group of nine (9) type II variations was submitted as result from a pharmacovigilance audit conducted by the UK Medicines and Healthcare products Regulatory Agency (MHRA) on 29-31 May and 19-20 July 2012, where it was identified that the EU Summary of Product Characteristics (SmPC) for Suboxone should be aligned with the current CCDS. The variations included proposed changes to the SmPC and the package leaflet, and the MAH took this opportunity to bring the PI in line with the QRD template version 9. Eight (8) of the variations were acceptable and the sections 4.2, 4.4, 4.5, 4.8, 4.9 of the SmPC were updated, and in particular: - a clarification was added on withdrawal signs based on the available literature data. - a new or revised warning, respectively, on the risk of respiratory depression in non-opioid dependent individuals, children and pregnant women, supported by relevant pharmacovigilance data was added. - strengthening of the existing warning on hepatic injury, supported by relevant pharmacovigilance data, was done. - the warning related to the use of suboxone in patient with severe renal impairment was strengthened. This is supported by literature reference. - The general warning relevant to the administration of opioids was strengthened, supported by literature |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| to add information on the interaction of suboxone with Naltrexone, supported by relevant literature references. - Update to section 4.5 of the SmPC to add information on the interaction of suboxone and CYP3A4 inducers, supported by literature references. The PL was updated accordingly. The MAH took the opportunity to make minor editorial changes to the SmPC. Furthermore, the MAH proposed this opportunity to bring the PI in line with the QRD template version 9. The requested group of variations proposed amendments to the SmPC, Annex II, Labelling and Package Leaflet. C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC -   | references. - Additional information on the interaction of suboxone with full opioid agonist supported by literature references was introduced. - An update to the information on the interaction of suboxone with Naltrexone and CYP3A4 inducers was made, supported by relevant literature references. In addition, the CHMP considers the following variation not acceptable: - Update to section 4.8 of the SmPC, to reclassify 'injury' and 'heat stroke' under the MedDRA SOC 'drug withdrawal symptom', to add adverse events observed in post-marketing settings in accordance with current pharmacovigilance data.   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| MAH C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH C.I.3.b - Implementation of change(s) requested   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the MAH                                                                                                                                                                 |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0011    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                            | 19/09/2012 | 23/05/2014 | PL                               | Update of the Package Leaflet (PL) to introduce changes related to the readibility testing reports.                                                                                                                                                                                                                                                                                   |
| R/0008    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                     | 21/07/2011 | 16/09/2011 | SmPC, Annex II, Labelling and PL | Reviewing the efficacy and safety data available for Suboxone since the granting of the marketing authorisation revealed no new major safety concerns. From the clinical perspective the CHMP considered that the overall benefit- risk ratio of Suboxone remained unchanged and was positive. The CHMP was of the opinion that the renewal could be granted with unlimited validity. |
| IB/0009/G | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 02/08/2011 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                       |
| T/0006    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                         | 06/07/2010 | 06/08/2010 | SmPC, Labelling and PL           | The Marketing Authorisation has been transferred from SP Europe to RB Pharmaceuticals Ltd.                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

| N/0005   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 23/02/2009   | n/a        | PL               |                                                                                                                                                                                                                                                |
|----------|----------------------------------------------------------------------------------------------------|--------------|------------|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0004   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 22/01/2008   | n/a        | PL               |                                                                                                                                                                                                                                                |
| II/0003  | Update of the Package Leaflet Update of Package Leaflet                                            | 21/06/2007   | 30/07/2007 | PL               | The Package Leaflet has been updated to reflect the comments received following the User Readability Testing Assessment. More specifically a subheading titled \"Misuse and abuse\" was introduced in the Section 2 of the PL for clarification. |
| N/0002   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 24/04/2007   | n/a        | PL               |                                                                                                                                                                                                                                                |
| N/0001   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 20/12/2006   | n/a        | Labelling and PL |                                                                                                                                                                                                                                                |